Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Western Union Co — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.96 (market cap $8.48B), while Western Union Co trades at $6.05 (market cap $1.90B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 4.5× Western Union Co's market cap, and Western Union Co pays a 15.41% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Western Union Co for 96 Days on average.
| HNGE | WU | |
|---|---|---|
Market Cap | $8.48B | $1.90B |
Volume | 879,799 | 6,506,793 |
Sector | Health | Financials |
52-Week High | $105.14 | $10.28 |
52-Week Low | $31.17 | $5.90 |
Typical Hold Time | 0 Days | 96 Days |
Enterprise Value | $8.10B | $1.81B |
Dividend Yield | — | 15.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Western Union (WU) trades at $6.05, down 0.98% on the day and near its 52-week low of $6.00. The stock shows bearish technical signals with recent earnings misses in Q1 and Q2 2026. Fundamentally, WU maintains strong profitability with a 9.79% net margin and attractive valuation metrics including a P/E of 4.92. The company's $200 million cost-cutting initiative and Intermex acquisition aim to drive future growth despite revenue declines from $4.5B in 2022 to $4.05B in 2025.
WU presents a value opportunity with deep undervaluation but faces execution risks. The stock trades below analyst consensus target of $6.71, offering 11% upside potential. However, declining revenue trends, integration challenges from the Intermex acquisition, and competitive pressures in money transfer services create headwinds. Investor sentiment remains cautious with only 12% buy ratings from analysts, reflecting concerns about the company's digital transition and margin pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
